Company & Sponsor Intelligence
Rhode Island Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed5
Countries1
Therapeutic footprint
adhdalzheimersdepressionepilepsyout_of_scope
Indexed studies
NCT03840382Telemedicine for PrEP Throughout Mississippi
out_of_scope · United StatesNA
out_of_scope · United StatesNA
NCT00835627Treatment Trial for Psychogenic Nonepileptic Seizures
epilepsy · United StatesPHASE4
epilepsy · United StatesPHASE4
NCT00603369HIV, Abuse, and Psychiatric Disorders Among Youth
out_of_scope · United StatesPHASE1
out_of_scope · United StatesPHASE1
NCT01841905Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
alzheimers · United StatesUNKNOWN
alzheimers · United StatesUNKNOWN
NCT02290899Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder
adhd · United StatesCOMPLETED
adhd · United StatesCOMPLETED
NCT02053649Integrated Chronotherapy for Perinatal Depression
depression · United StatesNA
depression · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →